Julián Reyes-López

Dr. Julián Reyes-López

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
ACAngel R. Calderón-Moctezuma
Angel R. Calderón-Moctezuma
JRJulián Reyes-López
Julián Reyes-López
RRRené Rodríguez-Valdés
René Rodríguez-Valdés
MBMario Barbosa-Luna
Mario Barbosa-Luna
JRJosefina Ricardo-Garcell
Josefina Ricardo-Garcell
HHHebert Hernández-Montiel
Hebert Hernández-Montiel
Objective: Current treatment for borderline personality disorder (BPD) involves psychological and pharmacological interventions. However, neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS) may positively affect BPD symptomatology. The objective of this study was to evaluate the clinical and neuropsychological effects of rTMS on the dorsomedial prefrontal cortex (DMPFC) in BPD patients. Methods: Fourteen patients with BPD were randomized into two groups (active vs. sham) for 15 sessions of rTMS on the DMPFC. Clinical effects were measured using the Borderline Symptoms List (BSL), Clinical Global Impression Scale for BPD (CGI-BPD), Borderline Evaluation of Severity over Time (BEST), Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), and Barratt’s Impulsiveness Scale (BIS). Neuropsychological effects were determined by a Stop-Signal Task (SST), the Wisconsin Card-Sorting Test (WCST), and the Iowa Gambling Test (IGT). Results: Within-group comparison showed significant differences (p < 0.05) in CGI-BPD (total score and six of nine psychopathologic domains), BEST, HDRS, HARS, and IGT scores for active modality. Conclusion: The 5 Hz-DMPFC rTMS technique was well tolerated and lessened the severity of BPD symptomatology, especially abandonment, affective issues, interpersonal relationships, suicidal behavior, anger, and paranoid ideation. Cognitive improvement was seen in decision-making. Additional studies are needed to fully evaluate the effects of rTMS on BPD symptomatology. Clinical Trial Registration: NCT03832777.

1 October 2021 in Psychiatry Research
Verified
Journal Article
Closed access
RGRoque Roque Gy
Roque Roque Gy
JRJulián Reyes-López
Julián Reyes-López
RJRicardo Garcell J
Ricardo Garcell J
LMLópez Hidalgo M
López Hidalgo M
ALAguilar Fabré L
Aguilar Fabré L
GJGonzález Olvera J
González Olvera J

7 September 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Wendy Herrera-MoralesWendy Herrera-Morales
Wendy Herrera-Morales
JRJulián Reyes-López
Julián Reyes-López
KCKaren Nicte-Ha Tuz Castellanos
Karen Nicte-Ha Tuz Castellanos
DODesiree Ortegón-Abud
Desiree Ortegón-Abud
LRLeticia Ramírez-Lugo
Leticia Ramírez-Lugo
Luis Núñez-JaramilloLuis Núñez-Jaramillo
Luis Núñez-Jaramillo
ADHD is a neurodevelopmental disorder appearing in childhood but remaining in many cases in adults. There are both pharmacological and non-pharmacological approaches to treating ADHD, but they do not have the same efficacy in all subjects. Better knowledge of the neurophysiological basis of this disorder will allow for the design of more effective treatments. Studies performing qEEG analysis in children suggest the existence of subgroups of ADHD patients with different neurophysiological traits. There are fewer studies in adults, who might have undergone plastic changes allowing them to cope with ADHD symptoms along with brain maturation. Herein, we study cognitive performance and the theta/beta ratio in young adults with ADHD symptoms. We found that subjects with ADHD symptoms and low working memory performance (n = 30) present higher theta/beta ratios than controls (n = 40) at O2 and T6 in the eyes-closed condition, as well as a tendency toward a higher theta/beta ratio at O1 and Cz. Subjects with ADHD and high working memory performance (n = 50) do not differ from the controls in their theta/beta ratios at any derivation. Our results suggest that neuropsychological profiling could be useful for patient subgrouping. Further research will allow for the distinction of neuropsychological profiles and their neurophysiological correlates, leading to a better classification of ADHD subtypes, thus improving treatment selection.

1 January 2019 in Revista De Neurologia
Verified
Journal Article
Closed access
Wendy Herrera-MoralesWendy Herrera-Morales
Wendy Herrera-Morales
LRLeticia Ramírez-Lugo
Leticia Ramírez-Lugo
ESEfraín Santiago-Rodríguez
Efraín Santiago-Rodríguez
JRJulián Reyes-López
Julián Reyes-López
Luis Núñez-JaramilloLuis Núñez-Jaramillo
Luis Núñez-Jaramillo

25 December 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Wendy Herrera-MoralesWendy Herrera-Morales
Wendy Herrera-Morales
KCKaren Nicte-Ha Tuz Castellanos
Karen Nicte-Ha Tuz Castellanos
JRJulián Reyes-López
Julián Reyes-López
ESEfraín Santiago-Rodríguez
Efraín Santiago-Rodríguez
Luis Núñez-JaramilloLuis Núñez-Jaramillo
Luis Núñez-Jaramillo
Background/Objectives: Psychiatric conditions are highly prevalent and among the leading causes of disability worldwide. Comorbidities are common in psychiatric patients but are not adequately addressed in diagnostic manuals such as the DSM-5. Understanding the impact of comorbidities on patients’ symptoms and brain activity could improve the personalization of therapeutic approaches, leading to better outcomes. Given the complexity of this task, a feasible strategy is to examine how comorbidities affect brain activity and a condition commonly observed in psychiatric patients, such as cognitive impairment. Methods: In this study, we assessed impulsiveness, working memory performance, and theta/beta ratio in controls and in subjects exhibiting symptoms of depression, ADHD, and suicide risk. Participants differed in the presence of alcohol use disorders, in addition to the aforementioned symptoms, either presenting no alcohol use disorder (DAS), hazardous alcohol consumption (DAS-H), or risk of alcohol dependence (DAS-D). Results: All three comorbid groups (DAS, DAS-H, DAS-D) showed increased impulsiveness compared with controls, while the DAS-D group also exhibited higher motor impulsiveness than both the DAS and DAS-H groups. A widespread increase in theta/beta ratio was observed only in the DAS group. Conclusions: These results indicate that comorbid alcohol use disorders modulate motor impulsiveness and theta/beta ratio in subjects with symptoms of depression, ADHD, and suicide risk. The findings underscore the importance of considering comorbidities when personalizing treatment strategies for psychiatric patients.

5 July 2022 in Boletín Científico de la Escuela Superior Atotonilco de Tula
Verified
Journal Article
Open access
PDF file
Wendy Herrera-MoralesWendy Herrera-Morales
Wendy Herrera-Morales
JTJorgelina Barrios de Tomasi
Jorgelina Barrios de Tomasi
JRJulián Reyes-López
Julián Reyes-López
Luis Núñez-JaramilloLuis Núñez-Jaramillo
Luis Núñez-Jaramillo
La plasticidad sináptica es un mecanismo a través del cual el sistema nervioso modifica la cantidad y/o intensidad de sus conexiones sinápticas en diferentes regiones. Este mecanismo participa en la formación de memorias, pero también es importante para potenciar la recuperación del cerebro tras algún daño. En el artículo se revisarán algunos procesos en los que participa la plasticidad sináptica.